LOGO
LOGO

Pre-market Movers: IXHL, KLRS, HCTI, DOCS...

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024 lt

In Friday's pre-market trading, the biotech stocks which are making significant moves are: (as of 8.20 am ET).

In the Green

Incannex Healthcare Inc. (IXHL) is up over 32% at $0.35.
Kalaris Therapeutics, Inc. (KLRS) is up over 16% at $4.21.
Universe Pharmaceuticals INC (UPC) is up over 14% at $5.60.
Cabaletta Bio, Inc. (CABA) is up over 14% at $2.08.
Basel Medical Group Ltd (BMGL) is up over 12% at $2.95.
Tonix Pharmaceuticals Holding Corp. (TNXP) is up over 11% at $25.85.
NanoViricides, Inc. (NNVC) is up over 9% at $1.44.
Emergent BioSolutions Inc. (EBS) is up over 9% at $6.00.
Ovid Therapeutics Inc. (OVID) is up over 8% at $0.33.
Cingulate Inc. (CING)is up over 6% at $4.10.
Aligos Therapeutics, Inc. (ALGS) is up over 6% at $6.18.
Medicus Pharma Ltd. (MDCX) is up over 5% at $6.25.
Unicycive Therapeutics, Inc. (UNCY) is up over 5% at $0.58.
Zenas BioPharma, Inc. (ZBIO) is up over 5% at $10.25.
Imunon, Inc. (IMNN) is up over 4% at $0.59.
Bionano Genomics, Inc. (BNGO) is up over 4% at $4.09.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.